Pathfinder Cell Therapy (Pathfinder Cell Therapy) EPS (Basic) : $0.00 (TTM As of Sep. 2015)

View and export this data going back to . Start your Free Trial

What is Pathfinder Cell Therapy EPS (Basic)?

Pathfinder Cell Therapy's basic earnings per share (Basic EPS) for the three months ended in Sep. 2015 was $0.00. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Sep. 2015 was $0.00.

Pathfinder Cell Therapy's EPS (Diluted) for the three months ended in Sep. 2015 was $0.00. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Sep. 2015 was $0.00.

Pathfinder Cell Therapy's EPS without NRI for the three months ended in Sep. 2015 was $0.00. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Sep. 2015 was 0.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

Pathfinder Cell Therapy EPS (Basic) Historical Data

The historical data trend for Pathfinder Cell Therapy's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pathfinder Cell Therapy EPS (Basic) Chart

Pathfinder Cell Therapy Annual Data

Trend

Dec05

Dec06

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

EPS (Basic)

Get a 7-Day Free Trial

-0.02

Pathfinder Cell Therapy Quarterly Data
	Dec10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15
EPS (Basic)	Get a 7-Day Free Trial															-	-	-	-	-

Pathfinder Cell Therapy EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Pathfinder Cell Therapy's Basic EPS for the fiscal year that ended in Dec. 2014 is calculated as

Basic EPS (A: Dec. 2014 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-1.394	-	0)	/	667.161
	=	-0.00

Pathfinder Cell Therapy's Basic EPS for the quarter that ended in Sep. 2015 is calculated as

Basic EPS (Q: Sep. 2015 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-0.289	-	0)	/	667.161
	=	-0.00

EPS (Basic) for the trailing twelve months (TTM) ended in Sep. 2015 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00

Pathfinder Cell Therapy (OTCPK:PFND) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Pathfinder Cell Therapy EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Pathfinder Cell Therapy's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Pathfinder Cell Therapy (Pathfinder Cell Therapy) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pathfinder Cell Therapy Inc (OTCPK:PFND) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

N/A

Address

12 Bow Street, Cambridge, MA, USA, 02138

Website

http://www.pathfindercelltherapy.com

Pathfinder Cell Therapy Inc is a regenerative medicine company. It is engaged in developing novel cell-based and related therapies for the treatment of diabetes, renal diseases and medical conditions characterized by organ-specific cell damage. Further, the group has discovered a new mammalian cell type, which is able to stimulate damaged tissues to regenerate without the Pathfinder Cells ("PCs") themselves being incorporated into the new tissue. Geographically the business activities are functioned through the region of United States.

Executives

John J Alam	director	130 WAVERLY STREET, CAMBRIDGE MA 02139
John L Brooks	director	100 LOWDER BROOK DRIVE SUITE 2500, WESTWOOD MA 02090

Pathfinder Cell Therapy (Pathfinder Cell Therapy) Headlines

No Headlines